目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Age
1.2.3. Distribution Channel
1.2.4. Drug Class
1.2.5. Regional Scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Age outlook
2.2.3. Distribution channel outlook
2.2.4. Drug class outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Urinary Incontinence Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Urinary Incontinence Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. Pipeline Analysis

Chapter 4. Urinary Incontinence Therapeutics Market: Type Estimates & Trend Analysis
4.1. Urinary Incontinence Therapeutics Market Segment Dashboard
4.2. Urinary Incontinence Therapeutics Market: Type Movement Analysis
4.3. Urinary Incontinence Therapeutics Market by Type Outlook (USD Billion)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Stress Incontinence
4.5.1. Stress Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Urge Incontinence
4.6.1. Urge Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. Overflow Incontinence
4.7.1. Overflow Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.8. Functional Incontinence
4.8.1. Functional Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Urinary Incontinence Therapeutics Market: Drug Class Estimates & Trend Analysis
5.1. Urinary Incontinence Therapeutics Market Segment Dashboard
5.2. Urinary Incontinence Therapeutics Market: Drug Class Movement Analysis
5.3. Urinary Incontinence Therapeutics Market by Drug Class Outlook (USD Billion)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Anticholinergics
5.5.1. Anticholinergics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Beta-3 Adrenoceptor Agonists
5.6.1. Beta-3 Adrenoceptor Agonists Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. Alpha Blockers
5.7.1. Alpha Blockers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.8. Estrogen
5.8.1. Estrogen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9. Desmopressin
5.9.1. Desmopressin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.10. Tricyclic Antidepressants
5.10.1. Tricyclic Antidepressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Urinary Incontinence Therapeutics Market: Distribution Channel Estimates & Trend Analysis
6.1. Urinary Incontinence Therapeutics Market Segment Dashboard
6.2. Urinary Incontinence Therapeutics Market: Distribution Channel Movement Analysis
6.3. Urinary Incontinence Therapeutics Market by Distribution Channel Outlook (USD Billion)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospital Pharmacies
6.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Retail Pharmacies
6.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7. Online Pharmacies
6.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Urinary Incontinence Therapeutics Market: Gender Estimates & Trend Analysis
7.1. Urinary Incontinence Therapeutics Market Segment Dashboard
7.2. Urinary Incontinence Therapeutics Market: Gender Movement Analysis
7.3. Urinary Incontinence Therapeutics Market by Gender Outlook (USD Billion)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Male
7.5.1. Male Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Female
7.6.1. Female Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Urinary Incontinence Therapeutics Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030, (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030, (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. Pfizer Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Age benchmarking
9.2.1.4. Strategic initiatives
9.2.2. AbbVie Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Age benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Astellas Pharma Inc.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Age benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Johnson & Johnson
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Age benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Viatris Inc.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Age benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Age benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Sanofi S.A.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Age benchmarking
9.2.7.4. Strategic initiatives
9.2.8. GlaxoSmithKline plc
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Age benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Boehringer Ingelheim Pharmaceuticals, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Age benchmarking
9.2.9.4. Strategic initiatives
9.2.9.5. Strategic initiatives
9.2.9.6. Strategic initiatives
9.2.10. Bayer AG
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Age benchmarking
9.2.10.4. Strategic initiatives
9.2.10.5. Strategic initiatives
9.2.11. Ferring Pharmaceuticals
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Age benchmarking
9.2.11.4. Strategic initiatives
9.2.11.5. Strategic initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 4. Global urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 5. Global urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 6. Global urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 7. North America urinary incontinence therapeutics market, by region, 2018 - 2030, (USD Billion)
Table 8. North America urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 9. North America urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 10. North America urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 11. North America urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 12. U.S. urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 13. U.S. urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 14. U.S. urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 15. U.S. urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 16. Canada urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 17. Canada urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 18. Canada urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 19. Canada urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 20. Mexico urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 21. Mexico urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 22. Mexico urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 23. Mexico urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 24. Europe urinary incontinence therapeutics market, by country, 2018 - 2030, (USD Billion)
Table 25. Europe urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 26. Europe urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 27. Europe urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 28. Europe urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 29. UK urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 30. UK urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 31. UK urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 32. UK urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 33. Germany urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 34. Germany urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 35. Germany urinary incontinence therapeutics market, by distribution channel 2018 - 2030, (USD Billion)
Table 36. Germany urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 37. France urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 38. France urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 39. France urinary incontinence therapeutics market, by distribution channel 2018 - 2030, (USD Billion)
Table 40. France urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 41. Italy urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 42. Italy urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 43. Italy urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 44. Italy urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 45. Spain urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 46. Spain urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 47. Spain urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 48. Spain urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 49. Denmark urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 50. Denmark urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 51. Denmark urinary incontinence therapeutics market, by distribution channel 2018 - 2030, (USD Billion)
Table 52. Denmark urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 53. Norway urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 54. Norway urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 55. Norway urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 56. Norway urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 57. Sweden urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 58. Sweden urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 59. Sweden urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 60. Sweden urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 61. Asia Pacific urinary incontinence therapeutics market, by country, 2018 - 2030, (USD Billion)
Table 62. Asia Pacific urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 63. Asia Pacific urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 64. Asia Pacific urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 65. Asia Pacific urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 66. Japan urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 67. Japan urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 68. Japan urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 69. Japan urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 70. China urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 71. China urinary incontinence therapeutics market, by gender 2018 - 2030, (USD Billion)
Table 72. China urinary incontinence therapeutics market, by distribution channel 2018 - 2030, (USD Billion)
Table 73. China urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 74. India urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 75. India urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 76. India urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 77. India urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 78. Australia urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 79. Australia urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 80. Australia urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 81. Australia urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 82. South Korea urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 83. South Korea urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 84. South Korea urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 85. South Korea urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 86. Thailand urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 87. Thailand urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 88. Thailand urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 89. Thailand urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 90. Latin America urinary incontinence therapeutics market, by country, 2018 - 2030, (USD Billion)
Table 91. Latin America urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 92. Latin America urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 93. Latin America urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 94. Latin America urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 95. Brazil urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 96. Brazil urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 97. Brazil urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 98. Brazil urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 99. Argentina urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 100. Argentina urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 101. Argentina urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 102. Argentina urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 103. Middle East & Africa urinary incontinence therapeutics market, by country, 2018 - 2030, (USD Billion)
Table 104. Middle East & Africa urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 105. Middle East & Africa urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 106. Middle East & Africa urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 107. Middle East & Africa urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 108. South Africa urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 109. South Africa urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 110. South Africa urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 111. South Africa urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 112. Saudi Arabia urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 113. Saudi Arabia urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 114. Saudi Arabia urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 115. Saudi Arabia urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 116. UAE urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 117. UAE urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 118. UAE urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 119. UAE urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)
Table 120. Kuwait urinary incontinence therapeutics market, by type, 2018 - 2030, (USD Billion)
Table 121. Kuwait urinary incontinence therapeutics market, by gender, 2018 - 2030, (USD Billion)
Table 122. Kuwait urinary incontinence therapeutics market, by distribution channel, 2018 - 2030, (USD Billion)
Table 123. Kuwait urinary incontinence therapeutics market, by drug class, 2018 - 2030, (USD Billion)

List of Figures
Fig. 1. Information procurement
Fig. 2. Primary research pattern
Fig. 3. Market research approaches
Fig. 4. Value chain-based sizing & forecasting
Fig. 5. Market formulation & validation
Fig. 6. Urinary incontinence therapeutics market segmentation
Fig. 7. Market driver analysis (current & future impact)
Fig. 8. Market restraint analysis (current & future impact)
Fig. 9. SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10. Porter’s five forces analysis
Fig. 11. Urinary incontinence therapeutics market, type outlook key takeaways (USD billion)
Fig. 12. Urinary incontinence therapeutics market: type movement analysis (USD billion), 2023 & 2030
Fig. 13. Stress incontinence market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 14. Urge incontinence market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 15. Overflow Incontinence market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 16. Functional Incontinence market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 17. Others market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 18. Urinary incontinence therapeutics market, gender outlook key takeaways (USD billion)
Fig. 19. Urinary incontinence therapeutics market: gender movement analysis (USD billion), 2023 & 2030
Fig. 20. Male market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 21. Female market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 22. Urinary incontinence therapeutics market, distribution channel outlook key takeaways (USD billion)
Fig. 23. Urinary incontinence therapeutics market: distribution channel movement analysis (USD billion), 2023 & 2030
Fig. 24. Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 25. Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 26. Online pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 27. Urinary incontinence therapeutics market, drug class outlook key takeaways (USD billion)
Fig. 28. Urinary incontinence therapeutics market: drug class movement analysis (USD billion), 2023 & 2030
Fig. 29. Anticholinergics market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 30. Beta-3 adrenoceptor agonists market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 31. Alpha blockers market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 32. Estrogen market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 33. Desmopressin market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 34. Tricyclic antidepressants market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 35. Others market revenue estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 36. Urinary incontinence therapeutics market: regional key takeaways (USD billion)
Fig. 37. Urinary incontinence therapeutics market: regional outlook, 2023 & 2030, USD billion
Fig. 38. North America urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 39. U.S. urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 40. Canada urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 41. Mexico urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 42. Europe urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 43. UK urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 44. Germany urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 45. France urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 46. Spain urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 47. Italy urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 48. Norway urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 49. Denmark urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 50. Sweden urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 51. Asia Pacific urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 52. China urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 53. Japan urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 54. India urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 55. South Korea urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 56. Australia urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 57. Thailand urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 58. Latin America urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 59. Brazil urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 60. Argentina urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 61. Middle East and Africa urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 62. South Africa urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 63. Saudi Arabia urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 64. UAE urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 65. Kuwait urinary incontinence therapeutics market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 66. List of key emerging company’s/distribution channel disruptors/innovators